Cite
MLA Citation
Panos Kefalas et al.. “Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy.” Journal of market access & health policy, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100066561613.0x000007